Sandeep Nagra

Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

Charles Craddock, Nadira Jilani, Shamyla Siddique et al. · Biology of Blood and Marrow Transplantation · 2015 · 173 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

Charles Craddock, Aimee Jackson, Justin Loke et al. · Journal of Clinical Oncology · 2020 · 165 citations · Full text

Medicine, Oncology, Chemotherapy +14

Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature

Charles Craddock, Aimee E. Houlton, Lynn Quek et al. · Clinical Cancer Research · 2017 · 86 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Factors predicting long-term survival after T-cell depleted reduced intensity allogeneic stem cell transplantation for acute myeloid leukemia

Charles Craddock, Sandeep Nagra, Andrew Peniket et al. · Haematologica · 2009 · 85 citations · Full text

Medicine, Hematology, Oncology +15

Chemokine-mediated tissue recruitment of CXCR3+ CD4+ T cells plays a major role in the pathogenesis of chronic GVHD

Joanne Croudace, Charlotte Inman, Ben Abbotts et al. · Blood · 2012 · 82 citations · Full text

Life Sciences, Cell Biology, Immunology +17